Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans

Reliable serological assays are needed to understand the real impact of COVID-19. In order to compare the efficiency of different COVID-19 vaccines used in the National Vaccination Program in Tunisia, we have developed a quantitative in-house ELISA. The ELISA is based on the ectodomain of the SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Gdoura, Mariem, Ghaloum, Fatma Ben, Hamida, Meriem Ben, Chamsa, Wafa, Triki, Henda, Bahloul, Chokri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252535/
https://www.ncbi.nlm.nih.gov/pubmed/35788676
http://dx.doi.org/10.1038/s41598-022-15378-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252535/
https://www.ncbi.nlm.nih.gov/pubmed/35788676
http://dx.doi.org/10.1038/s41598-022-15378-1

Ejemplares similares